These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33908359)

  • 21. The granting of emergency use designation to COVID-19 candidate vaccines: implications for COVID-19 vaccine trials.
    Singh JA; Upshur REG
    Lancet Infect Dis; 2021 Apr; 21(4):e103-e109. PubMed ID: 33306980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current advances in the development of SARS-CoV-2 vaccines.
    Awadasseid A; Wu Y; Tanaka Y; Zhang W
    Int J Biol Sci; 2021; 17(1):8-19. PubMed ID: 33390829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experts Discuss COVID-19: Vaccine Allocation, Placebo Groups, and More.
    JAMA; 2020 Dec; 324(23):2354-2355. PubMed ID: 33320222
    [No Abstract]   [Full Text] [Related]  

  • 24. Challenge Trials: What Are the Ethical Problems?
    Hausman DM
    J Med Philos; 2021 Jan; 46(1):137-145. PubMed ID: 33236048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19 vaccines: the importance of transparency and fact-based education.
    Cohen AF; van Gerven J; Burgos JG; de Boer A; Foucher RAM; Flore H; Teitelbaum Z; van Eden W; Webb A; Cremers S
    Br J Clin Pharmacol; 2020 Nov; 86(11):2107-2110. PubMed ID: 33464636
    [No Abstract]   [Full Text] [Related]  

  • 26. Review of Current Vaccine Development Strategies to Prevent Coronavirus Disease 2019 (COVID-19).
    Bennet BM; Wolf J; Laureano R; Sellers RS
    Toxicol Pathol; 2020 Oct; 48(7):800-809. PubMed ID: 32926660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maintaining a Focus on Health Equity During the COVID-19 Vaccine Rollout.
    Martin EG; Birkhead GS; Holtgrave DR
    J Public Health Manag Pract; 2021 May-Jun 01; 27(3):226-228. PubMed ID: 33762538
    [No Abstract]   [Full Text] [Related]  

  • 28. COVID-19 Vaccines: Current Understanding on Immunogenicity, Safety, and Further Considerations.
    He Q; Mao Q; Zhang J; Bian L; Gao F; Wang J; Xu M; Liang Z
    Front Immunol; 2021; 12():669339. PubMed ID: 33912196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ethics and Professionalism on the Frontline: Controlled Human Infection Trials in COVID-19 Vaccine Development: Ethical Considerations.
    Lucido C
    S D Med; 2020 Oct; 73(10):490-492. PubMed ID: 33264530
    [No Abstract]   [Full Text] [Related]  

  • 30. SARS-CoV-2: vaccines in the pandemic era.
    Li DD; Li QH
    Mil Med Res; 2021 Jan; 8(1):1. PubMed ID: 33402220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccine nationalism: a predicament in ending the COVID-19 pandemic.
    Lagman JDN
    J Public Health (Oxf); 2021 Jun; 43(2):e375-e376. PubMed ID: 33730161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New placebo-controlled Covid-19 vaccine trials are ethically questionable; it's now about comparative effectiveness and availability of registered vaccines.
    Knottnerus JA
    J Clin Epidemiol; 2021 May; 133():175-176. PubMed ID: 33741502
    [No Abstract]   [Full Text] [Related]  

  • 33. Covid-19 Vaccine Trials and Incarcerated People - The Ethics of Inclusion.
    Strassle C; Jardas E; Ochoa J; Berkman BE; Danis M; Rid A; Taylor HA
    N Engl J Med; 2020 Nov; 383(20):1897-1899. PubMed ID: 33085884
    [No Abstract]   [Full Text] [Related]  

  • 34. Search for better COVID vaccines confounded by existing rollouts.
    Dolgin E
    Nature; 2021 Jan; 589(7842):340-341. PubMed ID: 33420405
    [No Abstract]   [Full Text] [Related]  

  • 35. Exploration and Ethical Analysis of Open-label Pediatric Vaccine Trials in a Pandemic.
    Wolfe ID; Patel A; Kociolek LK; Fazal A; Jhaveri R; Lantos JD
    Clin Ther; 2021 Jun; 43(6):e163-e172. PubMed ID: 34039479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Placebo use and unblinding in COVID-19 vaccine trials: recommendations of a WHO Expert Working Group.
    Singh JA; Kochhar S; Wolff J;
    Nat Med; 2021 Apr; 27(4):569-570. PubMed ID: 33727699
    [No Abstract]   [Full Text] [Related]  

  • 37. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19 vaccines and treatments nationalism: Challenges for low-income countries and the attainment of the SDGs.
    Nhamo G; Chikodzi D; Kunene HP; Mashula N
    Glob Public Health; 2021 Mar; 16(3):319-339. PubMed ID: 33317389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A COVID-19 vaccine-dare to dream.
    Phillis A
    Br J Community Nurs; 2020 Dec; 25(12):2-7. PubMed ID: 33275510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double standards redux.
    Macklin R
    Indian J Med Ethics; 2021; VI(2):1-7. PubMed ID: 33908355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.